Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus

BACKGROUND: The increasing emergence of multidrug-resistant Gram-positive bacterial infections necessitates new antibacterial agents with novel mechanisms of action that can be used to treat these infections. Lomitapide has been approved by FDA for years in reducing levels of low-density lipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yufang, Zhang, Yiying, Chen, Chengchun, Cheng, Hang, Deng, Xiangbin, Li, Duoyun, Bai, Bing, Yu, Zhijian, Deng, Qiwen, Guo, Jie, Wen, Zewen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040290/
https://www.ncbi.nlm.nih.gov/pubmed/35473561
http://dx.doi.org/10.1186/s12866-022-02535-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040290/
https://www.ncbi.nlm.nih.gov/pubmed/35473561
http://dx.doi.org/10.1186/s12866-022-02535-9

Ejemplares similares